Global Synthetic Biology Market to Reach US$28.8 Billion by the Year 2026

Abstract: Global Synthetic Biology Market to Reach US$28. 8 Billion by the Year 2026 . Synthetic biology is an interdisciplinary field of research that utilizes a combination of genetics, biology, engineering, computer science, and chemistry for altering the structure and functioning of microorganisms.

New York, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Synthetic Biology Industry" - https://www.reportlinker.com/p01375238/?utm_source=GNW
Synthetic biology is being used in a wide range of applications, including vaccine, diagnostic test, and drug development, and in food, agriculture, and manufacturing industries. Amid the ongoing COVID-19 pandemic, scientists are looking at synthetic biology as a way to speed up the process of vaccine development. For drug discovery, the enhanced accuracy and speed offered by modern synthetic biology tools can help in significantly accelerating drug development as well as reducing expenses. Technology advances in DNA synthesis, nano-liter scale screening, genome engineering, application of in vitro transcription, continuous and cell-free evolution formats, and machine learning and artificial intelligence are expected to widen opportunities for synthetic biology. Synthetic biology market is also expected to benefit immensely from plunging DNA sequencing and DNA synthesis costs. Other factors driving market growth include increase in the number of entities focused synthetic biology research, growing demand for cross-breed animals, growing incidence of oceanic oil spills, increased R&D funding on drug development, and an upsurge in demand for sustainable energy resources such as biofuels.

Amid the COVID-19 crisis, the global market for Synthetic Biology estimated at US$6.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2026, growing at a CAGR of 28.1% over the analysis period. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is projected to grow at a 29.5% CAGR to reach US$16.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enzymes segment is readjusted to a revised 27% CAGR for the next 7-year period. This segment currently accounts for a 22.9% share of the global Synthetic Biology market. The commanding position of the Oligonucleotides & Synthetic DNA segment is attributed to increasing uptake of synthetic RNA, synthetic DNA and synthetic genes that are used in a broad array of applications. Synthetic biology is used to engineer several microbial enzymes such as inulinase, xylanases, laccases, lipases and amylases among others. Synthetic biology tools such as genetic modification, nanotechnology and post translational modification can be used to modify microbial enzymes and enable their widespread application in various industries.

The U.S. Market is Estimated at $3.3 Billion in 2021, While China is Forecast to Reach $2.9 Billion by 2026

The Synthetic Biology market in the U.S. is estimated at US$3.3 Billion in the year 2021. The country currently accounts for a 39.8% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$2.9 Billion in the year 2026 trailing a CAGR of 32.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.3% and 27.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 29.3% CAGR while Rest of European market (as defined in the study) will reach US$3.8 Billion by the end of the analysis period. The US and Europe represent the largest markets for synthetic biology propelled by increased investments for promoting research and development activities in the rapidly evolving sector, strong support from government and private organizations, growing awareness, and high demand for synthetic biology-enabled products. Growth in the US is supported by strong investments in research and development. The region is also witnessing a growing interest for using synthetic biology for development of countermeasures against chemical and biological threats. Synthetic biology is also gaining popularity in developing countries such as India and China with research activities promoted and supported by the government.

Cloning Technology Kits Segment to Reach $4.6 Billion by 2026

Cloning kits refers to collections of reagents commonly used to perform rapid DNA fragments cloning. Advanced cloning kits based on synthetic biology combine standard DNA components to provide custom vector constructs. In the global Cloning Technology Kits segment, USA, Canada, Japan, China and Europe will drive the 26.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$939.9 Million in the year 2020 will reach a projected size of US$4.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$509.7 Million by the year 2026.


Select Competitors (Total 141 Featured)

• Agilent Technologies, Inc

• Amyris, Inc

• Arzeda

• Atum

• Codexis, Inc

• Creative Enzymes

• Cyrus Biotechnology, Inc

• Editas Medicine, Inc

• Eurofins Genomics Blue Heron LLC

• Eurofins Scientific

• GENEWIZ, Inc

• GeneWorks Pty Ltd

• Genscript Biotech Corporation

• Ginkgo Bioworks

• Integrated Dna Technologies, Inc

• New England Biolabs

• Novozymes A/S

• OriGene Technologies, Inc

• Sanofi S.A.

• Synthego Corporation

• TeselaGen Biotechnology Inc

• Thermo Fisher Scientific, Inc

• Twist Bioscience

Read the full report: https://www.reportlinker.com/p01375238/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual %
Change) for 2020 through 2022
COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology
Synthetic Biologists Create Slow-Growing Version of COVID-19 as
Vaccine Candidate
Role of Synthetic Biology in Combating COVID-19
Synthetic Biology - A New Interdisciplinary Field
Growing Importance of Synthetic Biology
Applications of Synthetic Biology
Synthetic Biology Tools
Technologies Involved
Market Prospects and Outlook
Regional Landscape
Major Challenges and Concerns
Teaming R&D Funding & Potential to Alter Molecular Landscape
Enable Global Synthetic Biology Market to Remain in High
Spirits
Synthetic Biology to Radically Change the World for Good with
Endless Applications
Competitive Landscape
Major Players by Industry Verticals
Select Market Participants
Synthetic Biology Startups Get Aggressive on Bioengineered
Product Commercialization
Compelling Breakthroughs Drive Funding
EXHIBIT 2: Top Funded Synthetic Biology Startups in Q2 2021
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Synthetic Biology Market Witnesses Significant Rise in Investments
Importance of Synthetic Biology for Investments
Efforts from Leading Players Bodes Well for Market Growth
Patent Landscape Gets Richer
EXHIBIT 3: Synthetic Biology Patent Landscape by Assignee
Countries (in %) : 2003-2020
EXHIBIT 4: Top 15 Patent Assignees in Synthetic Biology Domain:
2003-2018
Select Patent Assignees for Synthetic Biology in the US: 2019
Robotics and Workflow Automation Support Market Expansion
Advancements in Instrumentation Augurs Well
Improvements in Computer-Aided Biology
Fusion of AI and Synthetic Biology Expands Opportunities
Synthetic Biology Brings a Paradigm Shift in the Field of
Biological Research
DNA Sequencing Plays an Important Role
Plummeting Cost of DNA Sequencing Bolsters Market Growth
EXHIBIT 5: Cost per Genome Sequencing: 2001-2020
Food Scarcity to Fuel Synthetic Biology Application in Agriculture
Select Companies Engaged in Making Food Using Synthetic Biology
Synthetic Biology Aids in Development of Exotic and
Artificially Grown Meats and Proteins to Meet Future Food
Demand
Growing Demand for GM Crops Opens Up Growth Avenues
Synthetic Biology-based Ingredients Gain Traction
Role of Synthetic Biology in Producing Plants with Desirable
Characteristics
Synthetic Biology Gains Prominence in Biomedical Applications
Synthetic Genes open up a New World of Drug Development
Synthetic Biology to Transform Healthcare with Captivating
Advances in Biomedicine
Synthetic Biology Enables Creation of Advanced Biosensing Systems
Synthetic Biology Gains Significance in Production of Bio-Based
Chemicals and Biofuels
EXHIBIT 6: Global Biofuels Market in US$ Billion: 2019 and 2024
Synthetic Biology Gains Importance as Focus on Carbon Recycling
Increases
Synthetic Biology Disrupts the Cosmetics Sector
Capability of Synthetic Biology in Environmental Applications
Synthetic Biology Creates Buzz as Key Enabler of Exciting &
Dynamic Applications for Diverse Domains
Synthetic Biology for Advanced, Multifunctional Materials
Genetically Engineered Fabrics and Sustainable Dyes Using
Synthetic Biology to Transform Textile Industry
Select Synthetic Biology Offerings in Textile Industry
Personalized Medicine to Display Notable Leap Forward with
Synthetic Biology
3D Bio-Printing

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Synthetic Biology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 2: World Historic Review for Synthetic Biology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 3: World 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2015, 2021 & 2027

Table 4: World Current & Future Analysis for Oligonucleotides &
Synthetic DNA by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 5: World Historic Review for Oligonucleotides & Synthetic
DNA by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 6: World 12-Year Perspective for Oligonucleotides &
Synthetic DNA by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2015, 2021 & 2027

Table 7: World Current & Future Analysis for Enzymes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 8: World Historic Review for Enzymes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 9: World 12-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2015, 2021 & 2027

Table 10: World Current & Future Analysis for Cloning
Technology Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Cloning Technology Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 12: World 12-Year Perspective for Cloning Technology Kits
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 13: World Current & Future Analysis for Synthetic Cells
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 14: World Historic Review for Synthetic Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 15: World 12-Year Perspective for Synthetic Cells by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 16: World Current & Future Analysis for Xeno-Nucleic
Acids (XNA) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 17: World Historic Review for Xeno-Nucleic Acids (XNA) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 18: World 12-Year Perspective for Xeno-Nucleic Acids
(XNA) by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2021 & 2027

Table 19: World Current & Future Analysis for Chassis Organism
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 20: World Historic Review for Chassis Organism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 21: World 12-Year Perspective for Chassis Organism by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 22: World Current & Future Analysis for Nucleotide
Synthesis & Sequencing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Nucleotide Synthesis &
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 24: World 12-Year Perspective for Nucleotide Synthesis &
Sequencing by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2021 & 2027

Table 25: World Current & Future Analysis for Genome
Engineering by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 26: World Historic Review for Genome Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 27: World 12-Year Perspective for Genome Engineering by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 28: World Current & Future Analysis for Microfluidics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 29: World Historic Review for Microfluidics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 30: World 12-Year Perspective for Microfluidics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 31: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 33: World 12-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 34: World Current & Future Analysis for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 35: World Historic Review for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 36: World 12-Year Perspective for Pharmaceuticals &
Diagnostics by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2015, 2021 & 2027

Table 37: World Current & Future Analysis for Industrial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 38: World Historic Review for Industrial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 39: World 12-Year Perspective for Industrial by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 40: World Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 41: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 42: World 12-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 43: World Current & Future Analysis for Environmental by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 44: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 45: World 12-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 46: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 47: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 48: World 12-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 49: USA Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 51: USA 12-Year Perspective for Synthetic Biology by Tool -
Percentage Breakdown of Value Revenues for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2021 & 2027

Table 52: USA Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: USA Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 54: USA 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2021 &
2027

Table 55: USA Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: USA Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 57: USA 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2021 &
2027

CANADA
Table 58: Canada Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 59: Canada Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 60: Canada 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2021 & 2027

Table 61: Canada Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Other Technologies -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Canada Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 63: Canada 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2021 &
2027

Table 64: Canada Current & Future Analysis for Synthetic
Biology by Application - Pharmaceuticals & Diagnostics,
Industrial, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Canada Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 66: Canada 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2021 &
2027

JAPAN
Table 67: Japan Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 69: Japan 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2021 & 2027

Table 70: Japan Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: Japan Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 72: Japan 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2021 &
2027

Table 73: Japan Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Japan Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 75: Japan 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2021 &
2027

CHINA
Table 76: China Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: China Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 78: China 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2021 & 2027

Table 79: China Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 80: China Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 81: China 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2021 &
2027

Table 82: China Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: China Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 84: China 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2021 &
2027

EUROPE
Table 85: Europe Current & Future Analysis for Synthetic
Biology by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 87: Europe 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2015, 2021 & 2027

Table 88: Europe Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: Europe Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2019 and % CAGR

Table 90: Europe 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2021 & 2027

Table 91: Europe Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Other Technologies -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Europe Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 93: Europe 12-Year Perspective for Synthetic Biology by

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p01375238/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001